Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Clinical Immunology and Immunopathology|August 1, 1994
Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapyM K Connolly, E A Kitchens, B Chan, et al.Kidney International|February 13, 2001
Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsetsT Wada, A Schwarting, M S Chesnutt, et al.Scandinavian Journal of Immunology|July 1, 1982
Thymic influences on autoimmunity in MRL-lpr miceD Wofsy, J A Ledbetter, J R Roubinian, et al.The Journal of Rheumatology|February 24, 2001
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosusJ C Davis, M C Totoritis, J Rosenberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathwaysD I Daikh, B K Finck, P S Linsley, et al.Clinical Immunology and Immunopathology|May 12, 1998
Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr miceM S Chesnutt, B K Finck, N Killeen, et al.The Journal of Experimental Medicine|November 1, 1981
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr geneD Wofsy, E D Murphy, J B Roths, et al.Lupus|November 29, 2007
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)A Sinclair, G Appel, M A Dooley, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1985
Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cellsJ A Ledbetter, P J Martin, C E Spooner, et al.Immunology|December 3, 1999
The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin GP Jeddi, J Keusch, P M Lydyard, et al.Pageof 6